Mirum Pharmaceuticals's total assets for Q3 2025 were $785.12M, an increase of 8.17% from the previous quarter. MIRM total liabilities were $493.07M for the fiscal quarter, a 4.76% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.